Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
M3 Inc (2413 JP)
Watchlist
153
Analysis
Health Care
•
Japan
M3, Inc. supplies medical information services for doctors through the Internet. The Company also supports marketing of pharmaceutical companies and medical equipment manufacturers.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Lawson Inc
•
31 Jan 2017 14:30
Lawson Tender - 1 Week Left
The Smartkarma community has discussed the Lawson Inc (2651 JP) partial tender deal in several insights:As discussed in the "first Winnie", there...
Travis Lundy
Follow
405 Views
Share
bullish
•
M3 Inc
•
30 Jan 2017 11:11
M3 Inc Placement - Q3 Results Reiterates Strong Growth, Sell Down Likely to Be One-Off
Sony Corp (6758 JP) is selling 5.34% of M3 Inc (2413 JP) existing shares for approximately US$482m (JPY55.273bn). With this sale, it brings Sony's...
Zhen Zhou, Toh
306 Views
Share
bullish
•
Thematic (Sector/Industry)
•
01 Nov 2016 05:06
Some Actionable Ideas in the Biotechnology and Pharmaceutical Sector: October 31 Sector Update
Acadia Pharmaceuticals Inc (ACAD US), our portfolio company announced the initiation of a phase 2 study of Nuplazid in Alzheimer's related...
Dr. Bhavneesh Sharma, MD, MBA
359 Views
Share
bullish
•
Thematic (Sector/Industry)
•
25 Oct 2016 04:40
Key Drivers of Asia's Healthcare Sector
From a demand perspective, Asia’s population is growing as is longevity. On the supply side, Asia’s number of doctors, nurses, hospitals and...
Singapore Exchange Ltd (SGX)
Follow
3.5k Views
Share
bullish
•
Thematic (Sector/Industry)
•
19 Oct 2016 03:19
Recap of Key U.S. Biotechnology and Pharmaceutical Sector Events: October 17
Celgene (NASDAQ: CELG) announced successful phase 1b data of its antisense therapy GED-0301 in the treatment of Crohn's disease (48% remission rate...
Dr. Bhavneesh Sharma, MD, MBA
293 Views
Share
First
Previous
26
27
28
29
30
31
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.4
x